UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008043
Receipt number R000008785
Scientific Title The influence of medication for Crohn's disease on serological response to the influenza vaccination
Date of disclosure of the study information 2012/05/28
Last modified on 2019/06/23 15:13:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The influence of medication for Crohn's disease on serological response to the influenza vaccination

Acronym

Influence of Crohn's disease medication on influenza vaccination

Scientific Title

The influence of medication for Crohn's disease on serological response to the influenza vaccination

Scientific Title:Acronym

Influence of Crohn's disease medication on influenza vaccination

Region

Japan


Condition

Condition

Crohn's disease

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the effect of Crohn's disease-medications on the serological response to the influenza vaccine

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase IV


Assessment

Primary outcomes

Response Rate of post-vaccination antibody titters against Influenza B/Brisbane.

Key secondary outcomes

1;Response Rate of post-vaccination antibody titters against Influenza A/California,Victoria.
2; CDAI scores at each observation period


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Medicine Vaccine

Interventions/Control_1

Influenza Vaccination to Crohn's disease patients treated with Infliximab

Interventions/Control_2

Influenza Vaccination to Crohn's disease patients treated with Elemental diet

Interventions/Control_3

Influenza Vaccination to patients with upper-alimentary tract disorders (Disease-control)

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

1) Patients of Crohn's disease
with Infliximab treatments or elemental diet therapy (>1 year) who want to receive Influenza vaccination
2)Patients of upper alimentary tract disorders without crohn's disease and ulcerative colitis who have not been treated with steroid, immunomodulators, anti-TNF reagents, and elemental diet within 16weeks.(Disease Control)

Key exclusion criteria

1)Patients who have been treated with Cyclosporin, Tacrolimus, Methotrexate, Steroids, total parental nutrition,granulocyte/monocyte apheresis therapy within 16 weeks.
2) Patients with severe infection or its complications within 1 year.
3) Patients with severe heart, kidney,liver,blood disease or developmental disorders.
4) Patients with allergic disease (Generalized rash etc.)
5) Patients with history of convulsion.
6) Patients diagnosed as an immune deficiency.
7) Patients with respiratory disease (interstitial pneumonia, bronchial asthma etc.)
8) Patients with allergy against ingredients of Influenza vaccine, hen's egg,or ingredients of hen.
9) Patients with drug or alcohol dependence or its history
10) Patients participated other clinical trial within 16 weeks.
11)Other patients judged as inappropriate bu the physician.
12) Patients received anti-TNF agents within 1 year (Only Elemental diet Groups)
13) Patients do not desire to receive Influenza vaccination.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masayuki Saruta

Organization

The Jikei University School of Medicine

Division name

Division of Gastroenterology and Hepatology

Zip code


Address

3-25-8 Nishi-shinbashi, Minato-ku, Tokyo

TEL

03-3433-1111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Masayuki Saruta

Organization

The Jikei University School of Medicine

Division name

Division of Gastroenterology and Hepatology

Zip code


Address

3-25-8 Nishi-shinbashi, Minato-ku, Tokyo

TEL

03-3433-1111

Homepage URL


Email



Sponsor or person

Institute

The Jikei University School of Medicine
Division of Gastroenterology and Hepatology

Institute

Department

Personal name



Funding Source

Organization

self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京慈恵会医科大学(東京都)、昭和大学(東京都)虎ノ門病院(東京都)


Other administrative information

Date of disclosure of the study information

2012 Year 05 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2012 Year 02 Month 06 Day

Date of IRB

2011 Year 12 Month 09 Day

Anticipated trial start date

2012 Year 05 Month 01 Day

Last follow-up date

2012 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 05 Month 28 Day

Last modified on

2019 Year 06 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008785


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name